Skip to main content
main-content

Zeitschrift

Breast Cancer Research

Breast Cancer Research 2/2006

Sonderheft 2/2006

Breast cancer research: the past and the future

Inhaltsverzeichnis ( 56 Artikel )

01.11.2006 | Oral Presentation | Sonderheft 2/2006

Breast cancer susceptibility after BRCA1/2: finding the genes and potential practical applications

01.11.2006 | Oral Presentation | Sonderheft 2/2006

Translating breast cancer research into clinical practice — new approaches and better outcomes

01.11.2006 | Oral Presentation | Sonderheft 2/2006

Evolution of aromatase inhibitors as an endocrine treatment for breast cancer

01.11.2006 | Oral Presentation | Sonderheft 2/2006

BRCA1 transcriptionally regulates genes associated with the basal breast cancer phenotype

01.11.2006 | Oral Presentation | Sonderheft 2/2006

Regulation of recombinational repair by the familial breast cancer susceptibility protein BRCA2

01.11.2006 | Oral Presentation | Sonderheft 2/2006

Chromosome translocations may play a significant role in breast cancer

01.11.2006 | Oral Presentation | Sonderheft 2/2006

Regulation of human breast stem cells

01.11.2006 | Oral Presentation | Sonderheft 2/2006

Aberrant activation of Notch signalling in human breast cancer

01.11.2006 | Oral Presentation | Sonderheft 2/2006

Novel roles for integrins in tumour angiogenesis

01.11.2006 | Oral Presentation | Sonderheft 2/2006

Genome-wide RNAi to identify genes that confer synthetic lethality with BRCA1

01.11.2006 | Oral Presentation | Sonderheft 2/2006

Microarray studies reveal novel genes associated with endocrine resistance in breast cancer

01.11.2006 | Oral Presentation | Sonderheft 2/2006

Benefits of combined treatments using antiresorptive agents and cytotoxic drugs

01.11.2006 | Poster Presentation | Sonderheft 2/2006

Loss of C-terminal binding protein transcriptional corepressor leads to aberrant mitosis and cell death in breast cancer cells

01.11.2006 | Poster Presentation | Sonderheft 2/2006

Phenotypic characterization of mouse mammary epithelial stem and progenitor cells

01.11.2006 | Poster Presentation | Sonderheft 2/2006

Characterisation of the tumour suppressor gene ZACin breast tissue

01.11.2006 | Poster Presentation | Sonderheft 2/2006

Role of BRCT motif containing proteins in Chk1 activation

01.11.2006 | Poster Presentation | Sonderheft 2/2006

The NEUREGULIN1gene and breast cancer

01.11.2006 | Poster Presentation | Sonderheft 2/2006

hCLK2 couples FANCD2 to stalled replication forks and functions in the mammalian S-phase checkpoint

01.11.2006 | Poster Presentation | Sonderheft 2/2006

Poly(ADPribosyl)ation of CTCF: role in breast tumourigenesis

01.11.2006 | Poster Presentation | Sonderheft 2/2006

Investigating the role of Wnt signalling in lobuloalveolar development of the mammary gland

01.11.2006 | Poster Presentation | Sonderheft 2/2006

Inhibitor of apoptosis proteins in breast cancer

01.11.2006 | Poster Presentation | Sonderheft 2/2006

Characterization of peptide aptamers to the Anterior Gradient 2: a novel inhibitor of the tumour suppressor protein p53

01.11.2006 | Poster Presentation | Sonderheft 2/2006

Role of CASP8 D302H and other apoptosis gene variants in breast cancer

01.11.2006 | Poster Presentation | Sonderheft 2/2006

Functional analysis of the breast cancer associated transcriptional repressor PLU-1/JARID1B

01.11.2006 | Poster Presentation | Sonderheft 2/2006

Potential role of cyclin D1in DNA damage response

01.11.2006 | Poster Presentation | Sonderheft 2/2006

Functional analysis of normal and DCIS modified breast myoepithelial cells

01.11.2006 | Poster Presentation | Sonderheft 2/2006

AGR2, a novel metastasis inducing protein with an effect on breast cancer patient survival

01.11.2006 | Poster Presentation | Sonderheft 2/2006

Insulin-like growth factor signalling in oestrogen nonresponsive breast cancer cells

01.11.2006 | Poster Presentation | Sonderheft 2/2006

Role of the Brk tyrosine kinase in breast cancer progression

01.11.2006 | Poster Presentation | Sonderheft 2/2006

The emerging role of CD44 in regulating skeletal metastasis

01.11.2006 | Poster Presentation | Sonderheft 2/2006

Evaluation of migration-stimulating factor expression for breast cancer diagnosis and prognosis

01.11.2006 | Poster Presentation | Sonderheft 2/2006

Functional analysis of altered Tenascin isoform expression in breast cancer

01.11.2006 | Poster Presentation | Sonderheft 2/2006

Role of the metastasis suppressor tetraspanin CD82/KAI 1 in regulation of signalling in breast cancer cells

01.11.2006 | Poster Presentation | Sonderheft 2/2006

Expression of adrenomedullin in long-term oestrogen-deprived human breast cancer cells

01.11.2006 | Poster Presentation | Sonderheft 2/2006

Role of protein kinase B in breast cancer

01.11.2006 | Poster Presentation | Sonderheft 2/2006

Progress towards unlocking the secrets of oestrogen receptor beta in breast cancer

01.11.2006 | Poster Presentation | Sonderheft 2/2006

New molecular tools and optical technologies to dissect CXCR4 function in breast cancer

01.11.2006 | Poster Presentation | Sonderheft 2/2006

Regulation of cytochrome P450s in breast cancer and their role for tumour growth and anticancer chemotherapy

01.11.2006 | Poster Presentation | Sonderheft 2/2006

High-grade ER-negative tumour breast cancers are characteristic of both very young onset cases and patients with hereditary breast cancer

01.11.2006 | Poster Presentation | Sonderheft 2/2006

Association of gene variants in the transforming growth factor beta signalling pathways with invasive breast cancer risk

01.11.2006 | Poster Presentation | Sonderheft 2/2006

Effect of intermittent versus chronic energy restriction on breast cancer risk biomarkers in premenopausal women: a randomised pilot trial

01.11.2006 | Poster Presentation | Sonderheft 2/2006

Breast cancer in relation to childhood parental divorce and early adult psychiatric disorder in a British birth cohort

01.11.2006 | Poster Presentation | Sonderheft 2/2006

Increased regulatory T-cell numbers distinguish high-risk breast cancer patients and those at risk of late relapse

01.11.2006 | Poster Presentation | Sonderheft 2/2006

Development of anti-MUC1 DNA aptamers for the imaging and radiotherapy of breast cancer

01.11.2006 | Poster Presentation | Sonderheft 2/2006

Global histone modifications in breast cancer and their prognostic significance

01.11.2006 | Poster Presentation | Sonderheft 2/2006

The Cambridge breast intensity modulated radiotherapy trial

01.11.2006 | Poster Presentation | Sonderheft 2/2006

Why do most c-erbB-2/HER-2-positive breast cancer patients fail to respond to Herceptin?

01.11.2006 | Poster Presentation | Sonderheft 2/2006

Synergistic effects of cytotoxic drugs and antiresorptive agents in vitro and in vivo

01.11.2006 | Poster Presentation | Sonderheft 2/2006

Development of small-molecule transforming growth factor beta antagonists

01.11.2006 | Poster Presentation | Sonderheft 2/2006

Development of breast cancer immunotherapy using MUC1 retargeted T lymphocytes

01.11.2006 | Poster Presentation | Sonderheft 2/2006

Effects of combined treatment with Zometa and Taxol on endothelial cells in vitro

01.11.2006 | Poster Presentation | Sonderheft 2/2006

Breast cancer follow-up: a focus group and interview study

01.11.2006 | Poster Presentation | Sonderheft 2/2006

'I haven't had breast cancer but I've had a mastectomy anyway': do women with ductal carcinoma in situhave appearance concerns?

01.11.2006 | Poster Presentation | Sonderheft 2/2006

Setting a lower risk threshold for surveillance within breast cancer family services

01.11.2006 | Poster Presentation | Sonderheft 2/2006

Role of macrophages in breast cancer angiogenesis in vivo

01.11.2006 | Poster Presentation | Sonderheft 2/2006

Is transforming growth factor beta signalling required for breast cancer metastatic cell motility?

Aktuelle Ausgaben

Neu im Fachgebiet Onkologie

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Onkologie und bleiben Sie gut informiert – ganz bequem per eMail.

Bildnachweise